REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,059 | -79.9% | 22,687 | -82.4% | 0.00% | -100.0% |
| Q2 2023 | $1,366,386 | +32202.3% | 129,148 | -70.0% | 0.00% | -50.0% |
| Q1 2023 | $4,230 | -57.6% | 429,870 | -36.6% | 0.00% | -66.7% |
| Q4 2022 | $9,970 | -99.7% | 677,787 | +174.1% | 0.01% | +200.0% |
| Q3 2022 | $3,000,000 | +72.6% | 247,321 | +99.1% | 0.00% | +100.0% |
| Q2 2022 | $1,738,000 | -44.6% | 124,195 | -43.6% | 0.00% | -50.0% |
| Q1 2022 | $3,135,000 | -55.1% | 220,154 | -33.5% | 0.00% | -50.0% |
| Q4 2021 | $6,977,000 | +55.1% | 330,826 | +92.9% | 0.00% | +33.3% |
| Q3 2021 | $4,499,000 | +539.1% | 171,461 | +659.2% | 0.00% | – |
| Q2 2021 | $704,000 | -78.4% | 22,585 | -76.2% | 0.00% | -100.0% |
| Q4 2020 | $3,259,000 | -44.1% | 95,018 | -49.9% | 0.00% | -71.4% |
| Q3 2020 | $5,835,000 | -15.7% | 189,645 | -15.1% | 0.01% | -22.2% |
| Q2 2020 | $6,925,000 | – | 223,244 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |